Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical

Govt To Provide Industrial Park Facilities To Grow API, Pharma & Nutraceutical Industry

Indian pharma industry will continue to play a prominent role as the pharmacy of the world, the Chemicals and Fertilizers Ministry said in a statement.

Read More

China's Fosun To Seek Approval For Biontech's COVID-19 Second Vaccine, Ends Trials On First

Fosun is licensed to exclusively develop and commercialize COVID-19 vaccine products developed by using BioNTech's mRNA technology in mainland China, Hong Kong, Macau and Taiwan.

Read More

Healthcare Group Sanofi Offers To Buy Smaller Peer Kiadis For 308 Mln Euros

Shares in Kiadis, focused on cell-based immunotherapy products for the treatment of cancer, were up 245% in early trading. Sanofi shares were up 1.18%.

Read More

Sanofi Raises Outlook As Specialty Care And Vaccines Lift Sales

Revenue in Sanofi's vaccine arm was up 13.6% at constant exchange rates to 2 billion euros ($2.36 billion) in the third quarter, which it said was due to record flu sales.

Read More

Eli Lilly Strikes Optimistic Tone On COVID-19 Therapy After Trial Failure

Revenue rose 5% to $5.74 billion in the quarter, below analyst forecasts of $5.88 billion.

Read More

Novartis Third-Quarter Core Net Income Rises To $3.47 Billion

The Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.

Read More

GSK To Launch Late-Stage Testing Of Syncytial Virus Vaccine

RSV vaccine development has been fraught with setbacks for decades but the pharma industry is gearing up to bring a first inoculation to market over the next few years.

Read More

Fujifilm Seeks Approval For Avigan As COVID-19 Treatment In Japan

Fujifilm in July signed a deal with India's Dr Reddy's Laboratories and Dubai-based Global Response Aid to sell Avigan for COVID-19 globally, excluding in China, Japan and Russia.

Read More

Glenmark Pharma Gets USFDA Nod For Generic Drug

The company's US-based subsidiary has received final approval from the US Food and Drug Administration (USFDA) for the product which is a generic version of PF Prism CV's Rapamune tablets

Read More

China's Sinopharm Offers Experimental COVID-19 Vaccines To Students

China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group and U.S.-listed Sinovac Biotech.

Read More

J&J Pauses COVID-19 Vaccine Trials Due To Unexplained Illness In Participant

J&J's move follows a similar one by AstraZeneca Plc. In September, AstraZeneca paused late-stage trials of its experimental coronavirus vaccine, developed with the University of Oxford, due to an unexplained illness in a UK study participant.

Read More

Johnson & Johnson pauses vaccine trial after volunteer falls ill

Johnson & Johnson pauses vaccine trial after volunteer falls ill

Read More

AstraZeneca Still Waiting For FDA Go-Ahead To Resume U.S. Trial

A document posted online by Oxford university last week stated the illness in a British participant that triggered the pause on Sept. 6 may not have been associated with the vaccine.

Read More

BioNTech CEO Expects Vaccine Can Be Fridge-Stored For Two Weeks

A good vaccine should have an efficacy of at least 70% to 75% for it to quell the pandemic and that was also the yardstick that BioNTech had set itself.

Read More

Astrazeneca To Begin Phase 1/2 Clinical Trials Of Coronavirus Vaccine In Japan

Trials of the vaccine, known as AZD1222, will be conducted at multiple facilities in Japan, targeting 250 subjects, the company said in a release.

Read More